Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2001; 37:1883-1890
© 2001 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cantor, W. J.
Right arrow Articles by Ohman, E. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cantor, W. J.
Right arrow Articles by Ohman, E. M.

CLINICAL STUDY: INTERVENTIONAL CARDIOLOGY

Achieving optimal results with standard balloon angioplasty: can baseline and angiographic variables predict stent-like outcomes?

Warren J. Cantor, MD*, Anne S. Hellkamp, MS{dagger}, Eric D. Peterson, MD, MPH{dagger}, James P. Zidar, MD{dagger}, Patricia A. Cowper, PhD{dagger}, Michael H. Sketch, Jr, MD{dagger}, James E. Tcheng, MD{dagger}, Robert M. Califf, MD{dagger} and E. Magnus Ohman, MD{dagger}

* St. Michael’s Hospital, Toronto, Canada
{dagger} Duke Clinical Research Institute, Durham, North Carolina, USA

Manuscript received August 22, 2000; revised manuscript received January 30, 2001, accepted February 13, 2001.

Reprint requests and correspondence: Dr. Warren J. Cantor, St. Michael’s Hospital, Division of Cardiology, 30 Bond Street, Toronto, Ontario, Canada M5B 1W8.
cantorw{at}smh.toronto.on.ca

OBJECTIVES

To predict which patients might not require stent implantation, we identified clinical and angiographic characteristics associated with repeat revascularization after standard balloon angioplasty.

BACKGROUND

Stents reduce the risk of repeat revascularization but are costly and may lead to in-stent restenosis, which remains difficult to treat. Identification of patients at low risk for repeat revascularization may allow clinicians to reserve stents for patients most likely to benefit.

METHODS

Data from five interventional trials (5,146 patients) were pooled for analysis. We identified patients with optimal angiographic results (final diameter stenosis ≤30% and no dissection) after balloon angioplasty and determined the multivariable predictors of repeat revascularization.

RESULTS

Optimal angiographic results were achieved in 18% of patients after angioplasty. The repeat revascularization rate at six months was lower for patients with optimal results (20% vs. 26%, p < 0.001) but still higher than observed in stent trials. Independent predictors of repeat revascularization were female gender (odds ratio [OR] 1.67, p = 0.01), lesion length ≥10 mm (OR 1.62, p = 0.03) and proximal left anterior descending coronary artery lesions (OR 1.62, p = 0.03). For the 8% of patients with optimal angiographic results and none of these risk factors, the repeat revascularization and target vessel revascularization rates were 14% and 8% respectively, similar to rates after stent implantation. Cost analysis estimated that $78 million per year might be saved in the U.S. with a provisional stenting strategy using these criteria compared with elective stenting.

CONCLUSIONS

A combination of baseline characteristics and angiographic results can be used to identify a small group of patients at very low risk for repeat revascularization after balloon angioplasty. Provisional stenting for these low risk patients could substantially reduce costs without compromising clinical outcomes.

Abbreviations and Acronyms
  BENESTENT = BElgium-NEtherlands Stent
  CAVEAT = Coronary Angioplasty Versus Excisional Atherectomy Trial
  CK-MB = creatine kinase-MB
  EPIC = Evaluation of 7E3 for the Prevention of Ischemic Complications
  EPISTENT = Evaluation of Platelet IIb/IIIa Inhibitor for Stenting
  IMPACT II = Integrelin to Minimize Platelet Aggregation and Coronary Thrombosis II
  LAD = left anterior descending coronary artery
  MARCATOR = Multicenter American Research trial with Cilazapril after Angioplasty To prevent coronary Obstruction and Restenosis
  MI = myocardial infarction
  OPUS = Optimum Percutaneous transluminal coronary angioplasty compared with roUtine Stent
  PBC = Perfusion Balloon Catheter study
  QCA = quantitative coronary angiography
  SLR = stent-like result
  TVR = target vessel revascularization




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
D. A. Cox, G. W. Stone, C. L. Grines, T. Stuckey, D. J. Cohen, J. E. Tcheng, E. Garcia, G. Guagliumi, R. S. Iwaoka, M. Fahy, et al.
Outcomes of optimal or "stent-like"balloon angioplasty in acutemyocardial infarction: the CADILLAC trial
J. Am. Coll. Cardiol., September 17, 2003; 42(6): 971 - 977.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
F. Schiele, N. Meneveau, M. Gilard, J. Boschat, P. Commeau, L. P. Ming, P. Sewoke, M.-F. Seronde, M. Mercier, S. Gupta, et al.
Intravascular Ultrasound-Guided Balloon Angioplasty Compared With Stent: Immediate and 6-Month Results of the Multicenter, Randomized Balloon Equivalent to Stent Study (BEST)
Circulation, February 4, 2003; 107(4): 545 - 551.
[Abstract] [Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement